Afsaneh Goudarzi

Afsaneh Goudarzi

Auto-generated profile, based on publicly available information

Afsaneh Goudarzi

CNRS UMR 5309, INSERM U1209, Université Grenoble Alpes, Institute for Advanced Biosciences , Grenoble, France

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Molecular Cell
Verified
Journal Article
Open access
AGAfsaneh Goudarzi
Afsaneh Goudarzi
DZDi Zhang
Di Zhang
HHHe Huang
He Huang
SBSophie Barral
Sophie Barral
OKOh Kwang Kwon
Oh Kwang Kwon
SKSaadi Khochbin
Saadi Khochbin
Recently discovered histone lysine acylation marks increase the functional diversity of nucleosomes well beyond acetylation. Here, we focus on histone butyrylation in the context of sperm cell differentiation. Specifically, we investigate the butyrylation of histone H4 lysine 5 and 8 at gene promoters where acetylation guides the binding of Brdt, a bromodomain-containing protein, thereby mediating stage-specific gene expression programs and post-meiotic chromatin reorganization. Genome-wide mapping data show that highly active Brdt-bound gene promoters systematically harbor competing histone acetylation and butyrylation marks at H4 K5 and H4 K8. Despite acting as a direct stimulator of transcription, histone butyrylation competes with acetylation, especially at H4 K5, to prevent Brdt binding. Additionally, H4 K5K8 butyrylation also marks retarded histone removal during late spermatogenesis. Hence, alternating H4 acetylation and butyrylation, while sustaining direct gene activation and dynamic bromodomain binding, could impact the final male epigenome features.

31 October 2016 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
ZKZuzanna Kaczmarska
Zuzanna Kaczmarska
EOEsther Ortega
Esther Ortega
AGAfsaneh Goudarzi
Afsaneh Goudarzi
HHHe Huang
He Huang
SKSunjoo Kim
Sunjoo Kim
DPDaniel Panne
Daniel Panne

1 September 2018 in Cell Reports
Verified
Journal Article
Open access
HSHitoshi Shiota
Hitoshi Shiota
SBSophie Barral
Sophie Barral
TBThierry Buchou
Thierry Buchou
MTMinjia Tan
Minjia Tan
YCYohann Couté
Yohann Couté
SKSaadi Khochbin
Saadi Khochbin
Nuclear protein in testis (Nut) is a universal oncogenic driver in the highly aggressive NUT midline carcinoma, whose physiological function in male germ cells has been unclear. Here we show that expression of Nut is normally restricted to post-meiotic spermatogenic cells, where its presence triggers p300-dependent genome-wide histone H4 hyperacetylation, which is essential for the completion of histone-to-protamine exchange. Accordingly, the inactivation of Nut induces male sterility with spermatogenesis arrest at the histone-removal stage. Nut uses p300 and/or CBP to enhance acetylation of H4 at both K5 and K8, providing binding sites for the first bromodomain of Brdt, the testis-specific member of the BET family, which subsequently mediates genome-wide histone removal. Altogether, our data reveal the detailed molecular basis of the global histone hyperacetylation wave, which occurs before the final compaction of the male genome.

1 October 2014 in Journal of Molecular Biology
Verified
Journal Article
Closed access
AGAfsaneh Goudarzi
Afsaneh Goudarzi
HSHitoshi Shiota
Hitoshi Shiota
SRSophie Rousseaux
Sophie Rousseaux
SKSaadi Khochbin
Saadi Khochbin

9 June 2022 in Human Reproduction
Verified
Journal Article
Closed access
PDF file
FBFerran Barrachina
Ferran Barrachina
AIAlberto de la Iglesia
Alberto de la Iglesia
MJMeritxell Jodar
Meritxell Jodar
ASAda Soler-Ventura
Ada Soler-Ventura
CMCarme Mallofré
Carme Mallofré
RORafael Oliva
Rafael Oliva
Is histone H4 acetylation (H4ac) altered in the seminiferous tubules of patients affected by testicular tumours? A considerable dysregulation of H4ac was detected in the cells of the seminiferous tubules adjacent to testicular tumours of different aetiology and prior to any treatment, while no comparable alterations were observed in patients with disrupted spermatogenesis. Altered H4ac levels have been associated with a variety of testicular pathological conditions. However, no information has been available regarding potential alterations in the spermatogenic cells adjacent to the neoplasia in testicular tumour patients. A retrospective analysis using testicular sections from 33 men aged between 21 and 74 years old was performed. Three study groups were defined and subjected to double-blind evaluation: a control group with normal spermatogenesis (n = 6), patients with testicular tumours (n = 18) and patients with spermatogenic impairments (n = 8). One additional sample with normal spermatogenesis was used as a technical internal control in all evaluations. Immunohistochemistry against H4ac and, when needed, Placental-like alkaline phosphatase and CD117, was performed on testicular sections. The H4ac H-score, based on the percentage of detection and signal intensity, was used as the scoring method for statistical analyses. Protein expression data from the Human Protein Atlas were used to compare the expression levels of predicted secreted proteins from testicular tumours with those present in the normal tissue. We revealed, for the first time, a dramatic disruption of the spermatogenic H4ac pattern in unaffected seminiferous tubule cells from different testicular tumour patients prior to any antineoplastic treatment, as compared to controls (P < 0.05). Since no similar alterations were associated with spermatogenic impairments and the in silico analysis revealed proteins potentially secreted by the tumour to the testicular stroma, we propose a potential paracrine effect of the neoplasia as a mechanistic hypothesis for this dysregulation. Statistical analyses were not performed on the hypospermatogenesis and Leydig cell tumour groups due to limited availability of samples. To the best of our knowledge, this is the first report showing an epigenetic alteration in cells from active seminiferous tubules adjacent to tumour cells in testicular tumour patients. Our results suggest that, despite presenting spermatogenic activity, the global epigenetic dysregulation found in the testicular tumour patients could lead to molecular alterations of the male germ cells. Since testicular tumours are normally diagnosed in men at reproductive age, H4ac alterations might have an impact when these testicular tumour patients express a desire for fatherhood. This work was supported by the European Union Marie Curie European Training Network actions and by grants to R.O. from the ‘Ministerio de Economía y Competividad (Spain)’ (fondos FEDER ‘una manera de hacer Europa’, PI13/00699, PI16/00346 and PI20/00936) and from EU-FP7-PEOPLE-2011-ITN289880. J.C. was supported by the Sara Borrell Postdoctoral Fellowship, Acción Estratégica en Salud, CD17/00109. J.C. is a Serra Húnter fellow (Universitat de Barcelona, Generalitat de Catalunya). F.B. has received grants from the Ministerio de Educación, Cultura y Deporte para la Formación de Profesorado Universitario (Spain) (FPU15/02306). A.d.l.I. is supported by a fellowship of the Ministerio de Economía, Industria y Competitividad (Spain) (PFIS, FI17/00224). M.J. is supported by the Government of Catalonia (Generalitat de Catalunya, pla estratègic de recerca i innovació en salut, PERIS 2016-2020, SLT002/16/00337). The authors have no conflicts of interest to declare. N/A.

8 April 2013 in Epigenomics
Verified
Journal Article
Closed access
HSHitoshi Shiota
Hitoshi Shiota
AGAfsaneh Goudarzi
Afsaneh Goudarzi
SRSophie Rousseaux
Sophie Rousseaux
SKSaadi Khochbin
Saadi Khochbin